Cognitive-affective neuroscience of depersonalization

CNS Spectrums

Volumn 14, Issue 9, 2009, Pages 467-471

  Stein, Dan J ^a,b   Simeon, Daphne ^c,d  

^a UNIVERSITY OF CAPE TOWN   (South Africa)

^b MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^c ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^d BETH ISRAEL MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; GLUTAMIC ACID; LAMOTRIGINE; NEUROTRANSMITTER; OPIATE ANTAGONIST;

ARTICLE; CANNABIS SMOKING; CLINICAL INDICATOR; DEPERSONALIZATION; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; ENVIRONMENTAL FACTOR; EVOLUTIONARY ADAPTATION; HEREDITY; HUMAN; NEUROANATOMY; NEUROCHEMISTRY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PSYCHODYNAMICS; PSYCHOTHERAPY;

ADULT; AFFECT; BRAIN; BRAIN CHEMISTRY; COGNITION; COGNITIVE SCIENCE; DEPERSONALIZATION; ENVIRONMENT; HUMANS; MALE; NEUROSCIENCES; PSYCHIATRIC STATUS RATING SCALES;

EID: 70849090035     PISSN: 10928529     EISSN: None     Source Type: Journal    
DOI: 10.1017/S109285290002352X     Document Type: Article

References (73)

1. Simeon D, Gross S, Guralnik O, et al. Feeling unreal: 30 cases of DSM-III-R depersonalization disorder. Am J Psychiatry. 1997;154:1107-1113. (Pubitemid 27328827)
2. Simeon D. Depersonalisation disorder: a contemporary overview. CNS Drugs. 2004;18:343-354.
3. Sierra M, Berrios GE. The phenomenological stability of depersonalization: Comparing the old with the new. J Nerv Ment Dis. 2001;189:629-636. (Pubitemid 32905911)
4. Simeon D, Giesbrecht T, Knutelska M, et al. Alexithymia, absorption, and cognitive failures in depersonalization disorder a comparison to posttraumatic stress disorder and healthy volunteers. J Nerv Ment Dis. 2009;197:492-498.
5. Montagne B, Sierra M, Medford N, et al. Emotional memory and perception of emotional faces in patients suffering from depersonalization disorder. Br J Psychology. 2007;98:517-527.
6. Medford N, Brierley B, Brammer M, et al. Emotional memory in depersonalization disorder: a functional MRI study. Psychiatry Res. 2006;148:93-102. (Pubitemid 44750587)
7. Guralnik O, Schmeidler J, Simeon D. Feeling Unreal: Cognitive Processes in Depersonalization. Am J Psychiatry. 2000;157:103-109.
8. Guralnik O, Giesbrecht T, Knutelska M, et al. Cognitive functioning in depersonalization disorder. J Nerv Ment Dis. 2007;195:983-988.
9. Aderibigbe YA, Bloch RR, Walker WR. Prevalence of depersonalization and derealization experiences in a rural population. Soc Psychiatry Psychiatr Epidemiol. 2001;36:63-69. (Pubitemid 32303395)
10. Michal M, Wiltink J, Subic-Wrana C, et al. Prevalence, correlates, and predictors of depersonalization experiences in the German general population. J Nerv Ment Dis. 2009;197:499-506.
11. Hunter EC, Sierra M, David AS. The epidemiology of depersonalisation and derealisation. A systematic review. Soc Psychiatry Psychiatr Epidemiol. 2004;39:9-18. (Pubitemid 39369102)
12. Hunter EC, Phillips ML, Chalder T, et al. Depersonalisation disorder: a cognitive-behavioural conceptualisation. Behav Res Ther. 2003;41:1451-1467.
13. Kenna JC, Sedman G. Depersonalization in temporal-lobe epilepsy and the organic psychoses. Br J Psychiatry. 1965;111: 293-299.
14. Sierra M, Lopera F, Lambert MV, et al. Separating depersonalisation and derealisation: the relevance of the "lesion method". J Neurol Neurosurg Psychiatry. 2002;72:530-532.
15. Blanke O, Arzy S. The out-of-body experience: disturbed self-processing at the temporo-parietal junction. Neuroscientist. 2005;11:16-24. (Pubitemid 40223087)
16. Arzy S, Thut G, Mohr C, et al. Neural basis of embodiment: distinct contributions of temporoparietal junction and extrastriate body area. J Neurosci. 2006;26:8074-8081. (Pubitemid 44315132)
17. Devinsky O, Putnam F, Grafman J, et al. Dissociative states and epilepsy. Neurology. 1989;39:835-840.
18. Salanova V, Andermann F, Rasmussen T, et al. Parietal lobe epilepsy: clinical manifestations and outcome in 82 patients treated surgically between 1929 and 1988. Brain. 1995;118:607-627.
19. Simeon D, Guralnik O, Hazlett EA, et al. Feeling Unreal: A PET study of depersonalization disorder. Am J Psychiatry. 2000;157:1782-1788. (Pubitemid 30813134)
20. Irle E, Lange C, Weniger G, et al. Size abnormalities of the superior parietal cortices are related to dissociation in borderline personality disorder. Psychiatry Res. 2007;156:139-149. (Pubitemid 47600625)
21. Phillips ML, Medford N, Senior C, et al. Depersonalization disorder: thinking without feeling. Psychiatry Res. 2001;108:145-160. (Pubitemid 34072915)
22. Lemche E, Surguladze SA, Giampietro VP, et al. Limbic and prefrontal responses to facial emotion expressions in depersonalization. Neuroreport. 2007;18:473-477. (Pubitemid 46668037)
23. Lemche E, Anilkumar A, Giampietro VP, et al. Cerebral and autonomic responses to emotional facial expressions in depersonalisation disorder. Br J Psychiatry. 2008;193:222-228
24. Sierra M, Berrios GE. Depersonalization: neurobiological perspectives. Biological Psychiatry. 1998;44:898-908.
25. Phillips ML, Sierra M. Depersonalization disorder: a functional neuroanatomical perspective. Stress. 2003;6:157-165. (Pubitemid 37214009)
26. Stein DJ, Muller J. Cognitive-affective neuroscience of somatization disorder and functional somatic syndromes: Reconceptualizing the triad of depression-anxiety-somatic symptoms. CNS Spectr. 2008;13:379-384. (Pubitemid 351792220)
27. Stein DJ. Emotional regulation: Implications for the psychobiology of psychotherapy. CNS Spectr. 2008;13:195-198.
28. Roder CH, Michal M, Overbeck G, et al. Pain response in depersonalization: A functional Imaging study using hypnosis in healthy subjects. Psychother Psychosom. 2007;76:115-121. (Pubitemid 46145640)
29. Simeon D, Hollander E, Stein DJ, et al. Induction of depersonalization by the serotonin agonist meta-chlorophenylpiperazine. Psychiatry Res. 1995;58:161-164.
30. Sedman G, Kenna JC. Occurrence of depersonalization phenomena under LSD. Psychiatr Neurologia. 1964;147:129-137.
31. Rusconi AC, Carlone C, Muscillo M, et al. SSRI discontinuation syndrome: incidence and differences on three groups of patients treated with paroxetine. Rivista di Psichiatria. 2009;44:169-175.
32. Simeon D, Knutelska M, Nelson D, et al. Feeling unreal: a depersonalization disorder update of 117 cases. J Clin Psychiatry. 2003;64:990-997. (Pubitemid 37158243)
33. Medford N, Baker D, Hunter E, et al. Chronic depersonalization following illicit drug use: a controlled analysis of 40 cases. Addiction. 2003;98:1731-1736. (Pubitemid 38030781)
34. Mathew RJ, Wilson WH, Chiu NY, et al. Regional cerebral blood flow and depersonalization after tetrahydrocannabinol administration. Acta Psychiatr Scand. 1999;100:67-75.
35. Abel KM, Allin MPG, Kucharska-Pietura K, et al. Ketamine alters neural processing of facial emotion recognition in healthy men: an fMRI study. Neuroreport. 2003;14:387-391. (Pubitemid 36337936)
36. Sierra M, Senior C, Dalton J, et al. Autonomic response in depersonalization disorder. Arch Gen Psychiatry. 2002;59: 833-838
37. Sierra M, Senior C, Phillips ML, et al. Autonomic response in the perception of disgust and happiness in depersonalization disorder. Psychiatry Res. 2006;145:225-231. (Pubitemid 44768033)
38. Simeon D, Guralnik O, Knutelska M, et al. Basal norepinephrine in depersonalization disorder. Psychiatry Res. 2003;121:93-97.
39. Stanton BR, David AS, Cleare AJ, et al. Basal activity of the hypothalamic-pituitary- adrenal axis in patients with depersonalization disorder. Psychiatry Res. 2001;104:85-89.
40. Simeon D, Guralnik O, Knutelska M, et al. Hypothalamic-pituitary-adrenal axis dysregulation in depersonalization disorder. Neuropsychopharmacology. 2001;25:793-795. (Pubitemid 32995962)
41. Sierra-Siegert M, David AS. Depersonalization and individualism: The effect of culture on symptom profiles in panic disorder. J Nerv Ment Dis. 2007;195:989-995. (Pubitemid 350306552)
42. Simeon D, Guralnik O, Schmeidler J, et al. The role of childhood interpersonal trauma in depersonalization disorder. Am J Psychiatry. 2001;158:1027-1033. (Pubitemid 32623105)
43. Michal M, Beutel ME, Jordan J, et al. Depersonalization, mindfulness, and childhood trauma. J Nerv Ment Dis. 2007;195:693-696.
44. Kihlstrom JF. Dissociative disorders. Annu Rev Clin Psychol. 2005;1:227-253.
45. Mula M, Pini S, Cassano GB. The neurobiology and clinical significance of depersonalization in mood and anxiety disorders: a critical reappraisal. J Affect Disord. 2007;99:91-99.
46. Hollander E, Liebowitz MR, DeCaria C, et al. Treatment of depersonalization with serotonin reuptake blockers. J Clin Psychopharmacol. 1990;10: 200-203 (Pubitemid 20203775)
47. Segui J, Marquez M, Garcia L, et al. Depersonalization in panic disorder: a clinical study. Compr Psychiatry. 2000;41:172-178. (Pubitemid 30322482)
48. Mula M, Pini S, Preve M, et al. Clinical correlates of depersonalization symptoms in patients with bipolar disorder. J Affect Disord. 2009;115:252-256.
49. Michal M, Kaufhold J, Grabhorn R, et al. Depersonalization and social anxiety. J Nerv Ment Dis. 2005;193:629-632.
50. Sedman G, Kenna JC. Depersonalization and mood changes in schizophrenia. Br J Psychiatry. 1963;109:669-673.
51. Torch EM. Review of relationship between obsession and depersonalization. Acta Psychiatr Scand. 1978;58:191-198.
52. Lambert MV, Senior C, Fewtrell WD, et al. Primary and secondary depersonalisation disorder: a psychometric study. J Affect Disord. 2001;63:249-256. (Pubitemid 32200522)
53. Lambert MV, Sierra M, Phillips ML, et al. The spectrum of organic depersonalization: a review plus four new cases. J Neuropsychiatry Clin Neurosci. 2002;14:141-154. (Pubitemid 34556523)
54. Baker D, Hunter E, Lawrence E, et al. Depersonalisation disorder: clinical features of 204 cases. Br J Psychiatry. 2003;182:428-433.
55. Simeon D, kozin Ds, Segal K, Lerch B. Is depersonalization disorder initiated by illicit durg use any different? A survey of 394 adults. J Clin Psych. In press.
56. Sierra M, Berrios GE. The Cambridge Depersonalisation Scale: a new instrument for the measurement of depersonalisation. Psychiatry Res. 2000;93:153-164. (Pubitemid 30139482)
57. Simeon D, Guralnik O, Gross S, et al. The detection and measurement of depersonalization disorder. J Nerv Ment Dis. 1998;186:536-542.
58. Simeon D, Guralnik O, Schmeidler J. Development of a depersonalization severity scale. J Trauma Stress. 2001;14:341-349.
59. Mula M, Pini S, Calugi S, et al. Validity and reliability of the Structured Clinical Interview for Depersonalization-Derealization Spectrum (SCI-DER). Neuropsychiatr Dis Treat. 2008;4:977-986.
60. Simeon D, Kozin DS, Segal K, et al. De-constructing depersonalization: further evidence for symptom clusters. Psychiatry Res. 2008;157:303-306. (Pubitemid 350166565)
61. Sierra M, Baker D, Medford N, et al. Unpacking the depersonalization syndrome: an exploratory factor analysis on the Cambridge Depersonalization Scale. Psychol Med. 2005;35:1523-1532. (Pubitemid 41430689)
62. Simeon D, Guralnik O, Schmeidler J, et al. Fluoxetine therapy in depersonalisation disorder: randomised controlled trial. Br J Psychiatry. 2004;185:31-36. (Pubitemid 38951627)
63. Sierra M, Phillips ML, Ivin G, et al. A placebo-controlled, cross-over trial of lamotrigine in depersonalization disorder. J Psychopharmacol. 2003;17:103-105. (Pubitemid 36373147)
64. Nuller YL, Morozova MG, Kushnir ON, et al. Effect of naloxone therapy on depersonalization: a pilot study. J Psychopharmacol. 2001;15:93-95. (Pubitemid 32619585)
65. Simeon D, Knutelska M. An open trial of naltrexone in the treatment of depersonalization disorder. J Clin Psychopharmacol. 2005;25:267-270. (Pubitemid 40685793)
66. Sierra M, Baker D, Medford N, et al. Lamotrigine as an add-on treatment for depersonalization disorder: A retrospective study of 32 cases. Clin Neuropharmacol. 2006;29:253-258. (Pubitemid 44439997)
67. Simeon D, Stein DJ, Hollander E. Treatment of depersonalization disorder with clomipramine. Biol Psychiatry. 1998;44:302-303.
68. Jimenez-Genchi AM. Repetitive transcranial magnetic stimulation improves depersonalization: a case report. CNS Spectr. 2004;9:375-376. (Pubitemid 38649726)
69. Sierra M. Depersonalization disorder: pharmacological approaches. Expert Rev Neurother. 2008;8:19-26.
70. Mancini-Marie A, Fahim C, Potvin S, et al. Quetiapine: focus on emotional numbing in depersonalization disorder: an fMRI case report. Eur Psychiatry. 2006;21:574-577. (Pubitemid 44873074)
71. Medford N, Stringaris A, Sierra M, et al. Response to aversive stimuli in depersonalization disorder: neural activation patterns in two patients before and after treatment with lamotrigine. Biol Psychiatry. 2004;55:812.
72. Hunter ECM, Baker D, Phillips ML, et al. Cognitive-behaviour therapy for depersonalisation disorder: an open study. Behav Res Ther. 2005;43:1121-1130. (Pubitemid 40984737)
73. Frances A, Sacks M, Aronoff MS. Depersonalization: a self-relations perspective. Int J Psychoanal. 1977;58:325-331.